Tectonic Therapeutic (TECX) Current Leases (2022 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Current Leases of $1.2 million for Q1 2026, down 37.78% year-over-year from $1.9 million in Q1 2025, and up 31.16% quarter-over-quarter from $889000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Current Leases (2022 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Current Leases for 5 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 37.78% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 37.78% YoY), while the FY2025 annual figure was $889000.0, down 61.26% from the prior year.
- Current Leases advanced to $1.2 million in Q1 2026 per TECX's latest filing, from $889000.0 in the prior quarter.
- Across five years, Current Leases topped out at $2.6 million in Q1 2023 and bottomed at $224000.0 in Q1 2024.
- Historically, Current Leases has averaged $1.3 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 91.47% — and 2025, when it jumped 736.61%.
- Tectonic Therapeutic's Current Leases stood at $999000.0 in 2022, then jumped by 34.93% to $1.3 million in 2023, then jumped by 70.25% to $2.3 million in 2024, then plunged by 61.26% to $889000.0 in 2025, then surged by 31.16% to $1.2 million in 2026.
- Business Quant data shows TECX's Current Leases at $1.2 million in Q1 2026, $889000.0 in Q4 2025, and $725000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | -1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.58 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 889,000.00 |
| Sep 30, 2025 | 725,000.00 |
| Jun 30, 2025 | 451,000.00 |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 474,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 999,000.00 |